World COPD Day: Lung Association Offers Free Access to Lung Health Navigators to People with COPD Nationwide

CHICAGO, Nov. 19, 2025 /PRNewswire/ — Today is World COPD Day, and the American Lung Associationis…

Kvantify Qrunch – Quanteninformatik für chemische und biologische Innovationen nutzbar machen

KOPENHAGEN, Dänemark, 19. November 2025 /PRNewswire/ — Kvantify, ein dänisches Pionier-Unternehmen auf dem Gebiet der Quantencomputer-Software,…

Kvantify Qrunch – L’informatique quantique au service de l’innovation en chimie et en biologie

COPENHAGUE, Danemark, 19 novembre 2025 /PRNewswire/ — Kvantify – pionnier danois des logiciels d’informatique quantique –…

SHAKLEE SPARKLING PROTEIN™ RETURNS AFTER SELLING OUT IN RECORD TIME — A RUNAWAY SUCCESS IN LONGEVITY NUTRITION

MIAMI, Nov. 12, 2025 /PRNewswire/ –Shaklee, the original wellness company and pioneer in longevity nutrition, today…

John Apathy Joins DataJoint as Strategic Advisor, Strengthening Data and AI Leadership in Life Sciences R&D

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March…

Manulife Launches Global Longevity Institute Committing $350M by 2030 to Accelerate Progress on Lifelong Health and Financial Resilience

For the first time in decades, people are having real conversations about health care, “from the…

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

BRANFORD, Conn., Nov. 12, 2025 /PRNewswire/ — Azitra, Inc. (“Azitra”) (NYSE American: AZTR), a clinical stage…

27 YSM Faculty Members Recognized for Highly Cited Research

NEW HAVEN, Conn., Nov. 12, 2025 /PRNewswire/ — Twenty-sevenYale School of Medicine(YSM) faculty members were recognized…

Laronix Secures $3.2 Million Grant from the Australian Government to Bring its AI-Powered Voice Technology to the Market

BRISBANE, Australia, Nov. 12, 2025 /PRNewswire/ —Laronix, (“Laronix” or the “Company”), a commercial-stage medical technology (MedTech)…

WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight

WRN inhibitors are attracting increasing attention as a niche but fast-emerging segment within precision oncology, driven…